Search Results 601-610 of 18687 for hepatitis

  1. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated

  2. Nonalcoholic Steatohepatitis (NASH) Clinical Trials - Mayo Clinic Research

    ... hepatitis, and congestion associated with cardiac hepatopathy. Detection of such entities provides essential diagnostic, prognostic, and treatment ...

  3. Abacavir, dolutegravir, and lamivudine (oral route) - Mayo Clinic

    Hepatitis B or C, or history of—Use with caution. May make this condition worse. Kidney disease or; Liver disease, mild—Use is not recommended in patients ...

  4. Autoimmune Diseases Clinical Trials - Mayo Clinic Research

    ... hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC) ... hepatitis (DIAIH). Thyroid Autoimmunity Biobank Rochester, MN. We plan to ...

  5. NAFLD and NASH research update - Mayo Clinic

    Vargas, M.D., a gastroenterologist and hepatologist specializing in viral hepatitis and liver transplantation at Mayo Clinic's campus in Arizona. Dr. Vargas ...

  6. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    Participation eligibility · NOTE: If evidence of chronic hepatitis B virus (HBV) infection, HBV viral load must be undetectable and on suppressive therapy. · NOTE ...

  7. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

    Participation eligibility · Inability to undergo a liver biopsy. · Hepatitis B surface antigen (HBsAg) positive. · Hepatitis C antibody (HCVAb) positive with the ...

  8. Joel Streed | Mayo Clinic News Network - Page 96 of 170

    Hepatitis C, one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage ...

  9. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    those who are hepatitis B surface antigen positive or hepatitis B PCR positive and those who are hepatitis C PCR positive will be excluded - History of ...

  10. Abdominal pain When to see a doctor - Mayo Clinic

    See also. Abdominal aortic aneurysm · Acute liver failure · Addison's disease · Adrenal fatigue: What causes it? Alcoholic hepatitis · Alpha-gal syndrome ...